Duff & Phelps Investment Management Co. Buys 142,400 Shares of American Healthcare REIT, Inc. $AHR

Duff & Phelps Investment Management Co. grew its stake in American Healthcare REIT, Inc. (NYSE:AHRFree Report) by 129.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 252,400 shares of the company’s stock after purchasing an additional 142,400 shares during the quarter. Duff & Phelps Investment Management Co. owned approximately 0.15% of American Healthcare REIT worth $10,603,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Optiver Holding B.V. grew its holdings in American Healthcare REIT by 83.1% during the third quarter. Optiver Holding B.V. now owns 652 shares of the company’s stock worth $27,000 after buying an additional 296 shares in the last quarter. Trust Co. of Vermont bought a new position in American Healthcare REIT during the 3rd quarter valued at $28,000. Darwin Wealth Management LLC purchased a new position in American Healthcare REIT during the 2nd quarter worth $31,000. Total Investment Management Inc. bought a new stake in shares of American Healthcare REIT in the 2nd quarter worth $32,000. Finally, US Bancorp DE grew its stake in shares of American Healthcare REIT by 84.8% in the 3rd quarter. US Bancorp DE now owns 1,085 shares of the company’s stock worth $46,000 after acquiring an additional 498 shares in the last quarter. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Price Performance

AHR opened at $52.81 on Thursday. The firm has a market cap of $9.34 billion, a P/E ratio of 128.80, a PEG ratio of 2.45 and a beta of 0.95. The firm has a 50-day moving average of $49.51 and a 200 day moving average of $46.77. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.41 and a current ratio of 0.41. American Healthcare REIT, Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $54.67.

American Healthcare REIT (NYSE:AHRGet Free Report) last posted its quarterly earnings data on Thursday, February 26th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.40). The company had revenue of $604.08 million for the quarter, compared to analysts’ expectations of $617.49 million. American Healthcare REIT had a return on equity of 2.57% and a net margin of 3.09%.The business’s quarterly revenue was up 11.3% on a year-over-year basis. During the same quarter last year, the business posted $0.40 EPS. American Healthcare REIT has set its FY 2026 guidance at 1.990-2.050 EPS. On average, research analysts expect that American Healthcare REIT, Inc. will post 1.41 EPS for the current year.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 16th. Investors of record on Wednesday, December 31st were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Wednesday, December 31st. American Healthcare REIT’s payout ratio is 243.90%.

Insider Activity at American Healthcare REIT

In related news, Director Jeffrey T. Hanson sold 19,208 shares of the company’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was sold at an average price of $48.40, for a total value of $929,667.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.92% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on AHR shares. Morgan Stanley raised their price target on shares of American Healthcare REIT from $52.00 to $55.00 and gave the company an “overweight” rating in a research report on Thursday, November 20th. Jefferies Financial Group reaffirmed a “buy” rating on shares of American Healthcare REIT in a research report on Monday, December 15th. Scotiabank increased their price objective on shares of American Healthcare REIT from $55.00 to $59.00 and gave the company a “sector outperform” rating in a research note on Wednesday. Truist Financial dropped their target price on shares of American Healthcare REIT from $53.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 20th. Finally, The Goldman Sachs Group set a $60.00 target price on American Healthcare REIT in a report on Monday, March 2nd. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $53.25.

Check Out Our Latest Stock Report on American Healthcare REIT

About American Healthcare REIT

(Free Report)

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.

Further Reading

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.